INTCO Medical Named to the 2025 China Corporate ESG 100 Index

Recently, The 3rd China Brand Going Global Forum & The 2025 China Corporate ESG Blue Book Launch Event, jointly hosted by People’s Daily Overseas Edition Online, All-China Environment Federation, and China Quality Certification Center, was held in Beijing.
At the event, the 2025 China Corporate ESG 100 Index was officially released. With its strong and well-rounded performance across Environmental, Social, and Governance (ESG) dimensions, INTCO Medical was successfully selected for the index, receiving recognition from authoritative institutions.

Authoritative Index Highlighting Best Practices in Sustainable Development

The China Corporate ESG 100 Index, initiated and released by the All-China Environment Federation, is a leading sustainability evaluation framework that assesses enterprises across three core dimensions: Environmental, Social, and Governance. The index focuses on companies’ capabilities in green manufacturing, social responsibility fulfillment, and transparent governance mechanisms.

Through rigorous data evaluation and industry benchmarking, the index identifies the top 100 performers from thousands of participating enterprises, aiming to accelerate the integration and dissemination of sustainable development principles throughout China’s economic system.

INTCO Medical’s inclusion in the index not only reflects its solid achievements in green and low-carbon transformation, social contribution, and governance innovation, but also highlights its leading role in advancing sustainable practices across the healthcare manufacturing sector.

Comprehensive ESG Implementation for a Green and Sustainable Development System

Guided by its mission of “Global INTCO, Global Health” INTCO Medical regards ESG as a core pillar of corporate operations and continuously integrates ESG principles into its long-term strategy and daily management.

Environmental (E)

INTCO Medical continues to enhance resource efficiency through green manufacturing, energy structure optimization, and the adoption of clean energy solutions.
In 2024, the company intensified green technology innovation and application, achieving a 20.70% year-on-year reduction in carbon emissions per glove. Meanwhile, its photovoltaic power generation reached 3.538 million kWh, and wind power infrastructure development was initiated. In 2025, the wind power project at the Huaibei base in Anhui Province was officially put into operation.

Social (S)

Adhering to a people-oriented philosophy, INTCO Medical places strong emphasis on employee development and well-being. In 2024, the company’s cumulative R&D investment reached RMB 398 million, reinforcing technological innovation and core competitiveness.
INTCO Medical also actively fulfills its social responsibilities through public welfare initiatives, industrial poverty alleviation programs, and health education projects, delivering tangible benefits to broader communities.

Governance (G)

The company has established a sound corporate governance structure, continuously enhancing transparency and professionalism. A relatively high proportion of independent directors and female directors strengthens board diversity.
INTCO Medical has also improved its risk management, information security, and business ethics systems, ensuring long-term stable development through robust internal controls and external compliance mechanisms.

Continued Recognition from Global and Domestic ESG Evaluations

INTCO Medical has consistently disclosed annual ESG reports for many years and has demonstrated strong performance across multiple authoritative evaluation platforms.

The company has received the EcoVadis “Committed” Badge, maintained an A rating in Wind ESG for consecutive years, and achieved an upgrade to BBB in MSCI ESG ratings. It also became the first company in China’s medical glove industry to obtain Life Cycle Assessment (LCA) and carbon footprint certifications.

In addition, INTCO Medical has been recognized in the S&P Global Sustainability Yearbook and the Bloomberg Businessweek & Bloomberg Green Watchlist, among other international and domestic honors, reflecting its systematic achievements and industry influence in green development and social responsibility.

Corporate Statement: Continuing to Lead Sustainable Industry Development

Being included in the 2025 China Corporate ESG 100 Index represents high-level recognition of INTCO Medical’s long-term, strategic commitment to ESG principles and serves as authoritative endorsement of its green development and social responsibility practices.

Looking ahead, INTCO Medical will continue to strengthen its environmental initiatives, social responsibility programs, and governance capabilities, accelerate its green transformation, and strive to set a benchmark for sustainable development within the global healthcare manufacturing industry.